ArticleJournal of translational medicine2015

NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy.

Michel M van den Heuvel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.